全文获取类型
收费全文 | 834篇 |
免费 | 57篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 41篇 |
妇产科学 | 7篇 |
基础医学 | 69篇 |
口腔科学 | 65篇 |
临床医学 | 82篇 |
内科学 | 122篇 |
皮肤病学 | 8篇 |
神经病学 | 11篇 |
特种医学 | 191篇 |
外科学 | 81篇 |
综合类 | 75篇 |
预防医学 | 47篇 |
眼科学 | 4篇 |
药学 | 42篇 |
中国医学 | 24篇 |
肿瘤学 | 21篇 |
出版年
2024年 | 1篇 |
2022年 | 6篇 |
2021年 | 2篇 |
2020年 | 6篇 |
2019年 | 3篇 |
2018年 | 15篇 |
2017年 | 13篇 |
2016年 | 12篇 |
2015年 | 11篇 |
2014年 | 27篇 |
2013年 | 54篇 |
2012年 | 47篇 |
2011年 | 45篇 |
2010年 | 47篇 |
2009年 | 40篇 |
2008年 | 39篇 |
2007年 | 58篇 |
2006年 | 18篇 |
2005年 | 16篇 |
2004年 | 10篇 |
2003年 | 2篇 |
2002年 | 5篇 |
2001年 | 9篇 |
2000年 | 4篇 |
1999年 | 12篇 |
1998年 | 56篇 |
1997年 | 47篇 |
1996年 | 36篇 |
1995年 | 23篇 |
1994年 | 26篇 |
1993年 | 23篇 |
1992年 | 5篇 |
1991年 | 8篇 |
1990年 | 5篇 |
1989年 | 18篇 |
1988年 | 23篇 |
1987年 | 19篇 |
1986年 | 13篇 |
1985年 | 21篇 |
1984年 | 7篇 |
1983年 | 10篇 |
1982年 | 9篇 |
1981年 | 8篇 |
1980年 | 10篇 |
1979年 | 1篇 |
1978年 | 6篇 |
1977年 | 6篇 |
1976年 | 9篇 |
1975年 | 5篇 |
1954年 | 1篇 |
排序方式: 共有897条查询结果,搜索用时 109 毫秒
91.
目的应用超声手段探测儿童颈动脉内膜-中层厚度(IMT),探讨其与儿童肥胖类型的关系。方法依体质指数(BMI)、腰围身高比(WHtR)标准,入组外周性肥胖组160名(A组),内脏性肥胖150名(B组),正常体重儿童160名(正常对照组);应用超声手段探测各组儿童内脏脂肪厚度(VFT)和颈动脉内膜-中层厚度,比较3组间各项检测参数。结果内脏肥胖组VFT、IMT均高于外周性肥胖组及正常组,差异具有统计学意义(P〈0.05);外周性肥胖组VFT、IMT与正常组相似,差异没有显著性。结论IMT与肥胖类型相关,内脏性肥胖儿童VFT、IMT增加。实时超声检查技术为研究儿童肥胖类型提供了一种新的检测手段。 相似文献
92.
The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis 总被引:1,自引:0,他引:1
Kapetanos D Kokozidis G Kinigopoulou P Xiarchos P Antonopoulos Z Progia E Kitis G 《Hepato-gastroenterology》2007,54(74):556-560
BACKGROUND/AIMS: Acute pancreatitis is the most serious complication of endoscopic retrograde cholangiopancreatography (ERCP) but is not very common. A test that could predict the occurrence of pancreatitis would help to decide whether to discharge a patient after ERCP or not. The aim of this prospective study was to compare the value of serum amylase and elastase in the prediction of post-ERCP pancreatitis and its severity. METHODOLOGY: Ninety-seven patients underwent ERCP. Serum samples were taken before, two and six hours after ERCP for amylase and elastase measurement. Fifty-four patients (group A) were treated with continuous intravenous infusion of octreotide, beginning 6 hours before ERCP and terminating 24 hours after. Forty-three patients (group B) received no preventive treatment. RESULTS: In group A, 9 patients (16.6%) developed pancreatitis, 8 of them (14.8%) mild and 1 (1.8%) severe. Two patients in group B developed mild pancreatitis (p = 0.1). In all patients the predictive accuracy in the second hour for amylase >3N, >5N and elastase >N was 79%, 87% and 86% respectively. The likelihood ratio of positivity (LRP) was 3.6, 6.5 and 6.1. In the sixth hour the respective values were 76%, 86%, 85% and 4, 7.3 and 6.4. In group A, the respective values in the second hour were 85%, 91%, 94% and 5, 25.2, infinity, and in the sixth hour 85%, 94%, 98% and 5.7, 11.5, infinity. CONCLUSIONS: Serum amylase (with cutoff value >5N) and elastase (>N), 6 hours after ERCP, were the most accurate tests for the prediction of post-ERCP pancreatitis, especially in patients receiving octreotide. The measurement of serum elastase could supplement that of serum amylase in the prediction of more cases of post-ERCP pancreatitis. 相似文献
93.
Katodritou E Terpos E Zervas K Speletas M Kapetanos D Kartsios C Verrou E Banti A Effraimidou S Christakis J 《Annals of hematology》2007,86(5):369-376
The aim of the study was to evaluate the role of hypochromic erythrocytes (HYPO%) compared to “traditional” and novel markers
of iron status and erythropoiesis in recognizing iron-restricted erythropoiesis (IRE) and predicting response to erythropoietin
(rHuEPO) in anemic patients with myeloma and lymphoma. Forty-one newly diagnosed patients who received epoetin-beta at a subcutaneous
weekly dose of 30,000 IU for 6 weeks were studied. Response to rHuEPO was observed in 27 patients (65.8%). Twelve non-responders
received, additionally, 200 mg of IV iron sucrose, weekly, for 4 weeks. Evaluation of markers was performed at baseline and
on weeks 1, 2 and 6 for all patients and also on weeks 7–10 for non-responders to rHuEPO. Baseline HYPO%, at a cut-off value
of <5%, and an increment in reticulocyte absolute number (RETICS-AB) ≥ 50,000/μl and reticulocyte hematocrit (RETICS-Hct) ≥ 50%,
between baseline and week 2, were independent predictive factors for response to rHuEPO. We found that these markers had superior
predictive value for response to rHuEPO than four widely used predictive models. Furthermore, a baseline HYPO% count of above
5% proved superior over serum ferritin < 100 ng/ml and transferrin saturation < 20% in recognizing IRE. In conclusion, baseline
HYPO% either alone or in combination with RETICS-AB or RETICS-Hct after 2 weeks of rHuEPO treatment could be reliably used
in predicting response to rHuEPO. Additionally, HYPO% has proved a reliable marker for recognizing IRE before rHuEPO treatment
and, thus, could be used for identifying patients who will benefit from IV iron supplementation. 相似文献
94.
目的 探讨应用非每日千伏级锥形束CT(KVCBCT)校位能否改善摆位误差对鼻咽癌调强放疗(IMRT)剂量分布影响。方法 对14例行根治性IMRT的鼻咽癌患者治疗开始后连续5次用KVCBCT检测摆位误差,并将其均值作为系统误差预测值,若其>1.5 mm则在第6次离线校位。假设通过移床能完全校正系统误差,那么从第6次起实际各方向摆位误差值加上离线校位值可得到未行校位时的摆位误差值,在治疗计划系统中通过等中心移位重新计算剂量来模拟应用非每日校位策略前后摆位误差所致的剂量变化。结果 对10例系统误差预测值>1.5 mm者摆位误差明显降低了靶区剂量:98%大体肿瘤体积(GTV)所接受剂量(GTV-D98)平均减少3.8Gy(Z=-2.81,P=0.005),原发灶临床靶体积(CTVns) D95( CTVns-D95)平均减少4.8Gy(Z=-1.96,P=0.050),高危CTV1 -D95平均减少1.0Gy(Z=-2.82,P=0.005),低危CTV2-D95减少不明显(Z=-0.13,P=0.900)。应用非每日校位后明显减少了摆位误差的三维方向位移总量,均值从3.6 mm减少为2.6mm(t=2.00,P=0.000),GTV-D98平均增加3.8 Gy(Z=-2.70,P=0.007),CTVns-D95平均增加5.0Gy(Z=-2.15,P=0.030),CTV1 -D95平均增加0.9Gy(Z=-2.80,P=0.005),减少了危及器官剂量增加>3%、5%患者比例。结论 应用非每日KVCBCT校位能有效减少摆位误差对鼻咽癌IMRT剂量分布的不利影响。 相似文献
95.
目的:分析总结食管癌切除胸腹二区淋巴结清扫的手术疗效。方法:回顾分析1986年2月~2007年12月我院对中下段食管癌和上段食管癌分别采用Ivor—Lewis术式,即上腹正中、右胸后外侧二切口切除及Akiyama术式.即右胸后外侧、上腹正中、左颈部三切口切除,并作胸腹二区淋巴结清扫治疗胸段食管癌1690例的临床资料,总结胸腹二区淋巴结转移的发生率并随访1、3、5年的生存率。结果:全组手术切除率为97.86%(1690/1727)。全组有淋巴结转移782例,占46.27%,其中胸部淋巴结转移占38.93%(658/1690),腹部淋巴结转移占25.92%(438/1690),胸部淋巴结转移发生于最上纵隔位于气管食管沟及喉返神经旁占20.47%(346/1690),术后共有178例发生230例次各种并发症,总的并发症的发生率为13.6%(230/1690),其中肺部并发症为第一位,占34.3%,心律失常占17.4%,喉返神经损伤发生率为8.7%,吻合口瘘发生率为1.7%。术后1、3、5年的生存率分别为88.2%(1161/1316)、63.5%(634/998)和51.8%(331/639)。无淋巴结转移的5年生存率为65.2%(219/336),有淋巴结转移的5年生存率为32.3%(102/316)。结论:Ivor-Lewis术式和Akiyama术式胸腹腔有良好的显露,淋巴结清扫彻底、方便,尤其对右侧最上纵隔沿喉返神经旁淋巴结清扫便利。特别对有淋巴结转移的食管癌患者行胸、腹二区淋巴结清扫十分必要,能明显提高术后5年生存率。 相似文献
96.
97.
98.
99.
100.
The kinetic occipital (KO) region in man: an fMRI study 总被引:10,自引:8,他引:2
Van Oostende S; Sunaert S; Van Hecke P; Marchal G; Orban GA 《Cerebral cortex (New York, N.Y. : 1991)》1997,7(7):690-701
We used functional magnetic resonance imaging to explore, in individual
subjects, the properties of the kinetic occipital (KO) region, which
previous position emission tomography studies have shown to be involved in
the processing of kinetic boundaries. The KO region was significantly
activated in 23/25 subjects tested in the subtraction of uniform motion
from kinetic gratings. The KO region is genuinely specialized for
processing kinetic boundaries since it is significantly more activated by
kinetic gratings than by luminance-defined gratings, uniform motion or
transparent motion. This leaves only the kinetic boundaries, created by
discontinuities in motion direction, as the specific stimulus aspect,
activating the KO region. The KO region is anatomically and functionally
distinct from areas MT/V5, V3 and V3A. It also has minimal overlap with the
lateral occipital (LO) region. The selective activation of the KO region is
robust and relatively immune to changes in stimulus size, spatial frequency
and type of kinetic boundary. These results strongly argue for the view
that the KO region is a new, separate, functional region in human occipital
cortex.
相似文献